GeneDx Holdings Corp.

NasdaqGS WGS

GeneDx Holdings Corp. Dividend Yield on February 06, 2025: 0.00%

GeneDx Holdings Corp. Dividend Yield is 0.00% on February 06, 2025, a 0.00% change year over year. Dividend yield measures the dividend per share relative to stock's price value; higher yield suggests higher dividend return.

GeneDx Holdings Corp. 52-week high Dividend Yield is 0.00% on February 06, 2025, which is 0.00% below the current Dividend Yield.
GeneDx Holdings Corp. 52-week low Dividend Yield is 0.00% on February 06, 2025, which is 0.00% below the current Dividend Yield.
GeneDx Holdings Corp. average Dividend Yield for the last 52 weeks is 0.00%.

Key data

Date	Dividend Yield	Free Cash Flow Yield	Earnings Yield	Enterprise Value (EV)

NasdaqGS: WGS

GeneDx Holdings Corp.

CEO	Ms. Katherine A. Stueland
IPO Date	Nov. 4, 2020
Location	United States
Headquarters	North Tower
Employees	1,000
Sector	Healthcare
Industries Telehealth Artificial Intelligence (AI) Autonomous Driving Big Data Biotechnology Clinical Trials Pharmaceuticals Robotics

Description

GeneDx Holdings Corp. is a patient centered health intelligence company. It engages in transforming healthcare by applying AI and machine learning to multidimensional, longitudinal clinical and genomic data to build dynamic models of human health and defining optimal, individualized health trajectories. The firm, through its Centrellis health intelligence platform, generates a more complete understanding of disease and wellness and provides science-driven solutions to the most pressing medical needs. The company was founded by Eric Schadt in October 2015 and is headquartered in Stamford, CT.

Key trends

Past 5 years